Information about Ranibizumab
Ranibizumab is used for diabetic eye disease, wet age-related macular degeneration and macular oedema due to retinal vein occlusion.
How ranibizumab works
Ranibizumab is an anti-angiogenic medication. It works by blocking a protein called vascular endothelial growth factor (VEGF). This stops the growth and leakage of abnormal blood vessels in the eye(s) that may cause vision loss.
Common side effects of ranibizumab
Conjunctival hemorrhage, Eye pain, Eye inflammation, Eye floaters, Increased intraocular pressure
Available Medicine for Ranibizumab
- ₹17000Intas Pharmaceuticals Ltd1 variant(s)
- ₹70160Novartis India Ltd1 variant(s)
- ₹23960Novartis India Ltd1 variant(s)
Expert advice for Ranibizumab
- Ranibizumab is used for the treatment of eye diseases caused by diabetes, macular degeneration and macular swelling.
- It is administered directly into the eyeball by an eye specialist.
- It may cause temporary visual disturbances. Don't drive or do anything that requires mental focus until you know how Ranibizumab affects you.
- Inform your doctor if you experience increased eye pain and redness, blurred or decreased vision, or increased sensitivity to light.
Frequently asked questions for Ranibizumab
Q. Is Ranibizumab FDA approved?
Yes, Ranibizumab is approved by the FDA
Q. What is Ranibizumab injection and how does it work?
Ranibizumab injection belongs to a class of medications called vascular endothelial growth factor (VEGF) antagonists. Ranibizumab is used for the treatment of conditions that affect vision such as exudative (wet) neovascular age-related macular degeneration (AMD), macular edema (swelling) following retinal vein occlusion and macular edema (swelling) due to diabetes. Ranibizumab binds extracellular VEGF thereby stopping abnormal blood vessel growth and leakage in the eye(s) which may lead to vision loss in people with wet AMD.